Clinical Trial Update: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Uniplas with Cryosupernatant Plasma in thrombotic thrombocytopenic purpura was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Cryosupernatant Plasma
• Uniplas

Snippet

Sponsor: Octapharma | Conditions: Thrombotic Thrombocytopenic Purpura (TTP) | Phase 3 | Status: TERMINATED